This competitive renewal application (Phase III) aims to address new fundamental questions regarding neurotoxicants, aging, and structure and function relations in the brain. Over the past ten years, a consistent body of evidence suggests that lead causes important changes in the adult brain.
This research aims to understand how a neurotoxicant causes persistent or progressive structural change in the CNS, the relation of structural change to progressive functional loss, and insight on mediating factors (genetic polymorphisms, vascular health). In Phase II, 656 MRIs of the brain were obtained, volumes of 96 regions of interest (ROIs) were derived, and images were graded for white matter (WM) lesions using a standard method. In cross-sectional analysis, these observations were made: inverse associations between tibia lead and CNS volumes; direct associations between tibia lead and prevalence and severity of WM lesions; and direct associations between CNS volumes and neurobehavioral test scores (smaller volume, worse performance). The data now suggest that lead causes progressive functional decline in the adult CNS, and structural changes that are at least persistent, both beyond what is due to normal aging alone. To understand the progressive functional loss, research must investigate whether the structural lesion is persistent or progressive, whether WM and GM effects are linked, and whether there are genetic or vascular moderators of these effects. Funding is now sought to complete a second MRI on 500 subjects, another neurobehavioral assessment, and an evaluation of vascular health. The goals are to determine if tibia lead causes a persistent or a progressive structural lesion in the brain; if lead is a moderator of the effect of aging on CNS structure and function; how lead causes WM lesions using better WM imaging methods; how WM lesions, changes in GM volumes, and changes in function are related; and if vascular health is a mediator or moderator of lead and CNS injury and of structure and function relations. ? ?
| Fisher, Aaron; Caffo, Brian; Schwartz, Brian et al. (2016) Fast, Exact Bootstrap Principal Component Analysis for p > 1 million. J Am Stat Assoc 111:846-860 |
| Bobb, Jennifer F; Schwartz, Brian S; Davatzikos, Christos et al. (2014) Cross-sectional and longitudinal association of body mass index and brain volume. Hum Brain Mapp 35:75-88 |
| James, Bryan D; Glass, Thomas A; Caffo, Brian et al. (2012) Association of social engagement with brain volumes assessed by structural MRI. J Aging Res 2012:512714 |
| James, Bryan D; Caffo, Brian; Stewart, Walter F et al. (2011) Genetic risk factors for longitudinal changes in structural MRI in former organolead workers. J Aging Res 2011:362189 |
| Swihart, Bruce J; Caffo, Brian; James, Bryan D et al. (2010) Lasagna plots: a saucy alternative to spaghetti plots. Epidemiology 21:621-5 |
| Schwartz, Brian S; Caffo, Brian; Stewart, Walter F et al. (2010) Evaluation of cumulative lead dose and longitudinal changes in structural magnetic resonance imaging in former organolead workers. J Occup Environ Med 52:407-14 |
| Chen, Sining; Wang, Chi; Eberly, Lynn E et al. (2009) Adaptive control of the false discovery rate in voxel-based morphometry. Hum Brain Mapp 30:2304-11 |
| Schwartz, Brian S; Chen, Sining; Caffo, Brian et al. (2007) Relations of brain volumes with cognitive function in males 45 years and older with past lead exposure. Neuroimage 37:633-41 |
| Shih, Regina A; Hu, Howard; Weisskopf, Marc G et al. (2007) Cumulative lead dose and cognitive function in adults: a review of studies that measured both blood lead and bone lead. Environ Health Perspect 115:483-92 |
| Schwartz, Brian S; Hu, Howard (2007) Adult lead exposure: time for change. Environ Health Perspect 115:451-4 |
Showing the most recent 10 out of 21 publications
